NSPR today
$0.64-$0.13 (-16.77%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourStrong Bearish
15 minLeaning Bullish
5 minSymmetric Triangle
Daily trend turns up above $0.81
Key levels
Resistance$0.93
Resistance$0.81
Support$0.63
Support$0.43
Latest news & SEC filings
EarningsInspireMD Posts Q3 2026 Results
ProductInspireMD wins FDA approval for CGuard Prime in TCAR procedures
EarningsInspireMD posts Q3 adjusted loss of $0.11 per share, revenue $2.242M
All NSPR news →About InspireMD
InspireMD is a medical device company that develops stent systems for treating carotid artery disease. Its main product, CGuard, is a carotid stent with a mesh covering designed to prevent plaque from escaping during stenting procedures. The company also develops the SwitchGuard neuroprotection system for use in transcarotid artery revascularization. It sells its products in certain international markets and is seeking broader regulatory approvals in the United States.
Based on the company's 10-K filed Mar 18, 2026.
Nasdaq · Healthcare
InspireMD, Inc. (NSPR)
What Is the Price Target for NSPR?
SEPT Low Target
$3.00
SEPT Mid Target
$3.00
SEPT High Target
$3.00
Analyst Consensus
$3.00
Is NSPR a Buy or Sell Right Now?
Thesis
- •Revenue growing 28.1% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NSPR.
Start Free Trial →Is NSPR Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$2.49
30
Moat Score
NONE
4/9
Piotroski Score
-5.3
Altman Z-Score
What Is Smart Money Doing with NSPR?
Insider Signal
NEUTRAL
11 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Stuka Paul | director | Buy | 20,000 | $18K | May 27, 2026 |
| Gleason Shane Thomas | officer | Sale | 22,778 | $23K | May 19, 2026 |
| Gleason Shane Thomas | officer | Sale | 2,941 | $5K | Feb 2, 2026 |
| Gleason Shane Thomas | officer | Sale | 7,186 | $18K | May 30, 2025 |
| Gleason Shane Thomas | officer | Sale | 3,760 | $9K | May 29, 2025 |
| Gleason Shane Thomas | officer | Sale | 1,572 | $4K | May 27, 2025 |
| Gleason Shane Thomas | officer | Sale | 2,482 | $6K | May 23, 2025 |
| Gleason Shane Thomas | officer | Sale | 10,000 | $37K | Feb 25, 2025 |
| Gleason Shane Thomas | officer | Sale | 5,132 | $13K | Feb 4, 2025 |
| Gleason Shane Thomas | officer | Sale | 7,073 | $18K | Feb 3, 2025 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NSPR Growth Story
Revenue YoY
28.1%
3yr Revenue CAGR
20.2%
EPS Growth YoY
0%
FCF Growth YoY
-58.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for NSPR
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NSPR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:11:22 | $0.64 | 1,500 | $$960 | BUY |
| 18:11:22 | $0.64 | 1,500 | $$957 | SELL |
| 18:11:22 | $0.64 | 1,376 | $$876 | SELL |
| 18:01:52 | $0.63 | 2,250 | $$1K | SELL |
| 17:48:10 | $0.64 | 1,800 | $$1K | BUY |
5 dark pool trades shown · $$5K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for InspireMD, Inc. (NSPR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NSPR — frequently asked questions
What is NSPR stock price today?
InspireMD, Inc. (NSPR) is at $0.64, down 16.77% (-$0.13) at the Nov 13, 2026 close.
Why is NSPR stock moving today?
Latest NSPR news — Nov 13, 2026: InspireMD Posts Q3 2026 Results · Nov 13, 2026: InspireMD wins FDA approval for CGuard Prime in TCAR procedures
What is the NSPR price target?
The average analyst price target for NSPR is $3.00, ranging from $3 to $3, based on 1 analysts.
What do analysts rate NSPR?
Analyst ratings for NSPR: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did NSPR beat earnings?
NSPR last reported on Aug 17, 2026: EPS -$0.17 vs -$0.20 expected — a beat of 15.0%.
Does NSPR pay a dividend?
NSPR does not currently pay a dividend.
What are NSPR support and resistance levels?
Support: $0.63, $0.43. Resistance: $0.81, $0.93, $1.02.
What are insiders doing with NSPR?
Insider activity: NEUTRAL, 11 buys and 9 sells in the last 90 days.
What is the latest news on NSPR?
Nov 13, 2026: InspireMD Posts Q3 2026 Results · Nov 13, 2026: InspireMD wins FDA approval for CGuard Prime in TCAR procedures · Nov 12, 2026: InspireMD posts Q3 adjusted loss of $0.11 per share, revenue $2.242M